Royal Bank of Canada
RKDA icon

Royal Bank of Canada’s Arcadia Biosciences RKDA Stock Holding History

Royal Bank of Canada’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed – – 7343
2024
Q2 		$0 Hold
2
– – ﹤0.01% 7457
2024
Q1 		$0 Hold
2
– – ﹤0.01% 7502
2023
Q4 		$0 Hold
2
– – ﹤0.01% 7508
2023
Q3 		$0 Sell
2
-2
-50% -$8 ﹤0.01% 7495
2023
Q2 		$0 Hold
4
– – ﹤0.01% 7599
2023
Q1 		$0 Buy
4
+3
+300% +$32 ﹤0.01% 7409
2022
Q4 		$0 Sell
1
-12
-92% -$171 ﹤0.01% 7634
2022
Q3 		$0 Buy
+13
New +$443 ﹤0.01% 7783
2021
Q3 		– Sell
-14
Closed -$1K – 7826
2021
Q2 		$1K Sell
14
-238
-94% -$25.9K ﹤0.01% 7340
2021
Q1 		$28K Buy
+252
New +$30.9K ﹤0.01% 6231
2019
Q4 		– Sell
-38
Closed -$7K – 7072
2019
Q3 		$7K Buy
+38
New +$7.29K ﹤0.01% 5902
2018
Q3 		– Sell
-2
Closed -$1K – 6913
2018
Q2 		$1K Buy
+2
New +$1.09K ﹤0.01% 6384
2018
Q1 		– Hold
0
– – – 6720
2017
Q4 		– Hold
0
– – – 6821
2017
Q3 		– Hold
0
– – – 6934
2016
Q4 		– Sell
-1
Closed -$1K – 6752
2016
Q3 		$1K Hold
1
– – ﹤0.01% 6301
2016
Q2 		$1K Hold
1
– – ﹤0.01% 6262
2016
Q1 		$1K Hold
1
– – ﹤0.01% 6230
2015
Q4 		$2K Hold
1
– – ﹤0.01% 6373
2015
Q3 		$3K Hold
1
– – ﹤0.01% 6310
2015
Q2 		$6K Buy
+1
New +$6.22K ﹤0.01% 6207

Other funds holding RKDA

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Royal Bank of Canada's RKDA Position: Q3 2024 in Review

Royal Bank of Canada sold out of Arcadia Biosciences (RKDA) in Q3 2024, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in RKDA in Q2 2015 and held it in 18 quarters. The position peaked at $28K in Q1 2021. 13 funds tracked by Wall St. Rank hold RKDA as of Q3 2024.

  • Royal Bank of Canada reported no remaining Arcadia Biosciences position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2 Arcadia Biosciences shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Arcadia Biosciences in Q2 2015 and held it in 18 quarters.
  • Royal Bank of Canada's Arcadia Biosciences position peaked at $28K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.